Skip to content
Peptide.Guide
PreclinicalMitochondrialSubQ3x per weekPartial data

Humanin

Mitochondrial-derived peptide with cytoprotective effects across neurons, cardiomyocytes, and beta cells; a candidate longevity signaling peptide.

§ 01   Overview

Overview

Mitochondrial-derived peptide with cytoprotective effects across neurons, cardiomyocytes, and beta cells; a candidate longevity signaling peptide.

Strong preclinical data from Cohen lab and others. Early human biomarker studies; no late-stage trials.

§ 02   Mechanism

Mechanism of action

Humanin is a 24-amino-acid peptide encoded within mitochondrial 16S rRNA. It binds FPR2 and IL-6/CNTF-like receptors to activate STAT3 and protect cells from oxidative and apoptotic stress.

  • 01Neuroprotection in Alzheimer's models
  • 02Improved beta cell survival
  • 03Cardioprotection in ischemia models

§ 03   Dosing

Dosing protocol

Standard Protocol

Dose Range
500 mcg – 2 mg (research)
Route
SubQ
Frequency
3x per week
Cycle
8 weeks

§ 04   Evidence

Evidence & research

Preclinical

Strong preclinical data from Cohen lab and others. Early human biomarker studies; no late-stage trials.

FDA Status

Not FDA-approved.

§ 05   Stacks

Common stacks

§ 06   News

In the news

4 articles from the last 12 months · updates hourly

§ 07   Sourcing

Sourcing & supply

Regulatory status

Research-only, no commercial channel

No commercial channel exists. Available only as a research reagent from RUO suppliers. Use in humans is not established.

No suppliers in our directory currently stock this compound. For investigational or research-only compounds, legitimate channels may not exist outside clinical trials.

Browse full supplier directory

§ 09   Safety

Safety & side effects

Side effects

  • 01Insufficient human safety data

Contraindications

None specified.

This site is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide or supplement.